These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1742152)

  • 1. Lymphoproliferative diseases of uncertain classification.
    Monteverde A; Pileri S
    Ann Ital Med Int; 1991; 6(1 Pt 2):162-70. PubMed ID: 1742152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodeficiency-associated lymphoproliferative disorders.
    Knowles DM
    Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
    Cohen JI
    Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome.
    Carbone A; Spina M; Gloghini A; Tirelli U
    Am J Hematol; 2011 Feb; 86(2):170-9. PubMed ID: 21264899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
    Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects of Epstein-Barr-virus-associated lymphoproliferative disease].
    Kvell K; Balogh P; Németh P
    Orv Hetil; 2002 Apr; 143(14):713-9. PubMed ID: 11975391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma.
    Krueger GR; Manak M; Bourgeois N; Ablashi DV; Salahuddin SZ; Josephs SS; Buchbinder A; Gallo RC; Berthold F; Tesch H
    Anticancer Res; 1989; 9(6):1457-76. PubMed ID: 2560617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodeficiency-related Hodgkin lymphoma and its mimics.
    Said JW
    Adv Anat Pathol; 2007 May; 14(3):189-94. PubMed ID: 17452815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.
    Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    Transplantation; 2004 Feb; 77(3):431-7. PubMed ID: 14966421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
    Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
    Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benign (reactive) lymphoproliferation or malignant lymphoma?].
    Wilms K
    Z Gesamte Inn Med; 1991 Mar; 46(3):53-8. PubMed ID: 2038877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.
    Kojima M; Motoori T; Nakamura S
    Biomed Pharmacother; 2006 Dec; 60(10):663-72. PubMed ID: 17064872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant lymphoproliferative disorder: a review.
    Loren AW; Porter DL; Stadtmauer EA; Tsai DE
    Bone Marrow Transplant; 2003 Feb; 31(3):145-55. PubMed ID: 12621474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis.
    Purtilo DT; Yasuda N; Grierson HL; Okano M; Brichacek B; Davis J
    Princess Takamatsu Symp; 1987; 18():149-58. PubMed ID: 2852188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of immunodeficiency to lymphoid malignancy.
    Kersey JH; Shapiro RS; Filipovich AH
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S10-2. PubMed ID: 2840629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
    Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
    J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.